1. Home
  2. MIST vs RCMT Comparison

MIST vs RCMT Comparison

Compare MIST & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • RCMT
  • Stock Information
  • Founded
  • MIST 2003
  • RCMT 1971
  • Country
  • MIST Canada
  • RCMT United States
  • Employees
  • MIST N/A
  • RCMT N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • RCMT Professional Services
  • Sector
  • MIST Health Care
  • RCMT Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • RCMT Nasdaq
  • Market Cap
  • MIST 145.3M
  • RCMT 172.2M
  • IPO Year
  • MIST N/A
  • RCMT N/A
  • Fundamental
  • Price
  • MIST $1.97
  • RCMT $26.56
  • Analyst Decision
  • MIST Strong Buy
  • RCMT Strong Buy
  • Analyst Count
  • MIST 3
  • RCMT 2
  • Target Price
  • MIST $6.33
  • RCMT $33.50
  • AVG Volume (30 Days)
  • MIST 1.2M
  • RCMT 47.0K
  • Earning Date
  • MIST 11-11-2025
  • RCMT 11-06-2025
  • Dividend Yield
  • MIST N/A
  • RCMT N/A
  • EPS Growth
  • MIST N/A
  • RCMT N/A
  • EPS
  • MIST N/A
  • RCMT 1.76
  • Revenue
  • MIST N/A
  • RCMT $299,916,000.00
  • Revenue This Year
  • MIST N/A
  • RCMT $15.03
  • Revenue Next Year
  • MIST N/A
  • RCMT $7.49
  • P/E Ratio
  • MIST N/A
  • RCMT $15.04
  • Revenue Growth
  • MIST N/A
  • RCMT 11.01
  • 52 Week Low
  • MIST $0.63
  • RCMT $13.18
  • 52 Week High
  • MIST $2.75
  • RCMT $28.27
  • Technical
  • Relative Strength Index (RSI)
  • MIST 67.34
  • RCMT 55.00
  • Support Level
  • MIST $1.75
  • RCMT $26.00
  • Resistance Level
  • MIST $1.83
  • RCMT $27.55
  • Average True Range (ATR)
  • MIST 0.09
  • RCMT 1.07
  • MACD
  • MIST 0.02
  • RCMT -0.04
  • Stochastic Oscillator
  • MIST 79.49
  • RCMT 37.36

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

Share on Social Networks: